The Effects of GLP-1 Receptor Agonists on Visceral Fat and Liver Ectopic Fat in an Adult Population With or Without Diabetes and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Long-term weight maintenance typically requires continued therapy or sustained behavioral changes established during treatment
The fact that there's a medically approved prescription for managing weight and staying healthier, in my lifetime, feels like relief, like redemption, like a gift, and not something to hide behind and once again be ridiculed for
"I use a lot of GLP-1s because they are shown to reduce the risk of dying from heart disease by up to 20%, depending on the population
The Phase 2 trial did include lower-dose groups (1mg, 4mg, 8mg), all of which showed meaningful weight loss, just less than the 12mg group
I am sympathetic to anyone who wishes to try a GLP-1 RA for AUD